MicroRNA provides insight into understanding esophageal cancer

Thoracic Cancer

Volumn 2, Issue 4, 2011, Pages 134-142

  Li, Xiaobo ^a   Wainscott, Caitlin ^a   Xi, Yaguang ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Biomarker; Esophageal cancer; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; DOXORUBICIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FLUOROURACIL; KRUPPEL LIKE FACTOR 4; LIPOCORTIN 1; MESSENGER RNA; MICRORNA; MICRORNA 100; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 15B; MICRORNA 192; MICRORNA 200A; MICRORNA 21; MICRORNA 375; MICRORNA 9; POLO LIKE KINASE 1; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; VINCRISTINE;

3' UNTRANSLATED REGION; BARRETT ESOPHAGUS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; COMPETITIVE INHIBITION; DOWN REGULATION; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS MUCOSA; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MEDLINE; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 84861368896     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00059.x     Document Type: Review

References (48)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
2. Jemal A, Siegel R, Xu J etal. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Guo Y, Chen Z, Zhang L etal. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
4. Friedman RC, Farh KK, Burge CB etal. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
5. Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009; 9: 703-11.
6. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
7. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
8. Lee YS, Kim HK, Chung S etal. Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 2005; 280: 16635-41.
9. Takamizawa J, Konishi H, Yanagisawa K etal. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-6.
10. Carmell MA, Xuan Z, Zhang MQ etal. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 2002; 16: 2733-42.
11. Karube Y, Tanaka H, Osada H etal. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111-15.
12. Howell PM, Jr, Li X, Riker AI etal. MicroRNA in Melanoma. Ochsner J 2010; 10: 83-92.
13. Luthra R, Singh RR, Luthra MG etal. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-78.
14. Kan T, Sato F, Ito T etal. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-700.
15. Lee KH, Goan YG, Hsiao M etal. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 2009; 315: 2529-38.
16. Zhang C, Wang C, Chen X etal. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010; 56: 1871-9.
17. Matsushima K, Isomoto H, Kohno S etal. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010; 82: 138-44.
18. Matsushima K, Isomoto H, Yamaguchi N etal. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med 2011; 9: 30.
19. Hu Y, Correa AM, Hoque A etal. Prognostic significance of differentially expressed miRNA in esophageal cancer. Int J Cancer 2011; 128: 132-43.
20. Kimura S, Naganuma S, Susuki D etal. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.
21. Akagi I, Miyashita M, Ishibashi O etal. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 2011. doi: 10.1111/j.1442-2050.2011.01177.x.
22. Hiyoshi Y, Kamohara H, Karashima R etal. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-22.
23. Fassan M, Pizzi M, Battaglia G etal. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol 2010; 63: 692-6.
24. Kano M, Seki N, Kikkawa N etal. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNA target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-14.
25. Wu BL, Xu LY, Du ZP etal. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17: 79-88.
26. Hummel R, Watson DI, Smith C etal. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 2011; 15: 429-38.
27. Tsuchiya S, Fujiwara T, Sato F etal. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 2011; 286: 420-8.
28. Xi Y, Nakajima G, Gavin E etal. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007; 13: 1668-74.
29. Smith CM, Watson DI, Michael MZ etal. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010; 16: 531-7.
30. Maru DM, Singh RR, Hannah C etal. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol 2009; 174: 1940-8.
31. Yang H, Gu J, Wang KK etal. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 2009; 15: 5744-52.
32. Wijnhoven BP, Hussey DJ, Watson DI etal. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg 2010; 97: 853-61.
33. Fassan M, Volinia S, Palatini J etal. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer 2010. doi: 10.1002/ijc.25823.
34. Bansal A, Lee IH, Hong X etal. Feasibility of MicroRNAs as biomarkers for barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am J Gastroenterol 2011; 106: 1055-63.
35. Liu Q, Lv GD, Qin X etal. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol Biol Rep 2011. doi: 10.1007/s11033-011-0854-7.
36. Mori Y, Ishiguro H, Kuwabara Y etal. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Report 2009; 2: 235-9.
37. Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer Res 2010; 12: 210.
38. Tian Y, Luo A, Cai Y etal. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010; 285: 7986-94.
39. Feber A, Xi L, Pennathur A etal. MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. Ann Thorac Surg 2011; 91: 1523-30.
40. Ogawa R, Ishiguro H, Kuwabara Y etal. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-9.
41. Mathe EA, Nguyen GH, Bowman ED etal. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-200.
42. Nguyen GH, Schetter AJ, Chou DB etal. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 2010; 16: 5824-34.
43. Li X, Lin R, Li J. Epigenetic Silencing of MicroRNA-375 Regulates PDK1 Expression in Esophageal Cancer. Dig Dis Sci 2011. doi: 10.1007/s10620-011-1711-1.
44. Zhang H, Li M, Han Y etal. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 2010; 55: 2545-51.
45. Hong L, Han Y, Zhang H etal. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010; 251: 1056-63.
46. Hamano R, Miyata H, Yamasaki M etal. Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway. Clin Cancer Res 2011; 17: 3029-38.
47. Ito T, Sato F, Kan T etal. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer. Int J Cancer 2010. doi: 10.1002/ijc.25874.
48. Ma WJ, Lv GD, Tuersun A etal. Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep 2010; 38: 3253-60.